Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. - Wikidata - wikimedia - TriplyDB

Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.

Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.

http://www.wikidata.org/entity/Q48629603

about

Brain resuscitation in the drowning victim Co-evolution of the MHC class I and KIR gene families in rhesus macaques: ancestry and plasticity Imaging of prehospital stroke therapeutics Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical Treatments Novel NMDA receptor modulators: an update Neuroprotection for stroke: current status and future perspectives Next-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis'The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory Tonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy.Targeting protein-protein interactions with trimeric ligands: high affinity inhibitors of the MAGUK protein family Network-Based Approach to Identify Potential Targets and Drugs that Promote Neuroprotection and Neurorepair in Acute Ischemic Stroke IL1R9 Is Evolutionarily Related to IL18BP and May Function as an IL-18 Receptor.The future of stroke thrombolysis.Tetramethylpyrazine nitrone, a multifunctional neuroprotective agent for ischemic stroke therapy.Efficacy of the PSD95 inhibitor Tat-NR2B9c in mice requires dose translation between species.Memory enhancement by targeting Cdk5 regulation of NR2B.A fast multiparameter MRI approach for acute stroke assessment on a 3T clinical scanner: preliminary results in a non-human primate model with transient ischemic occlusion Whole body MRI of the non-human primate using a clinical 3T scanner: initial experiences.Postsynaptic scaffold protein Homer 1a protects against traumatic brain injury via regulating group I metabotropic glutamate receptors.Research on the traditional Chinese medicine treating gastrointestinal motility in diabetic rats by improving biomechanical remodeling and neuroendocrine regulation.Restoring neuroprotection through a new preclinical paradigm: translational success for NA-1 in stroke therapy Neuronal necrosis is regulated by a conserved chromatin-modifying cascade.Pathophysiologic cascades in ischemic stroke Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction.Nonhuman primate models in translational regenerative medicine.Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial.A more consistent intraluminal rhesus monkey model of ischemic stroke.Temporal evolution of ischemic lesions in nonhuman primates: a diffusion and perfusion MRI study.PET Demonstrates Functional Recovery after Treatment by Danhong Injection in a Rat Model of Cerebral Ischemic-Reperfusion Injury.Dehydroascorbic Acid Attenuates Ischemic Brain Edema and Neurotoxicity in Cerebral Ischemia: An in vivo Study.Rigidified clicked dimeric ligands for studying the dynamics of the PDZ1-2 supramodule of PSD-95.Ocular Dominance Plasticity after Stroke Was Preserved in PSD-95 Knockout Mice.Scaffolding protein Homer1a protects against NMDA-induced neuronal injury.Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury.Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection.Two-photon imaging of cerebral hemodynamics and neural activity in awake and anesthetized marmosets.The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults.Molecular pathways: dysregulated glutamatergic signaling pathways in cancer Neuroprotective effect of a novel Chinese herbal decoction on cultured neurons and cerebral ischemic rats

P2860

Q23909719-82830445-1955-4250-86F5-CB494CA91A50 Q26797239-DA2B947A-70B8-48BC-8CDD-AC645227CA03 Q26797275-C2329D1B-F8D3-479F-9840-E3B69EB2E112 Q26800178-6CB4B55E-E4F7-4F2D-9A52-8F62B0FC8607 Q26849614-CAA95A05-6951-415B-A9E5-5530CA1D188D Q26853031-A6B8D532-3062-4C1D-8A43-D81C476A6DDA Q26865345-B09D13A2-E66B-41CB-86EC-243CB2B8F6EC Q26992363-1E31C5CF-9993-414C-A402-A2D82C33DF62 Q27319930-37844367-4EA8-45AC-B2FF-FF1E09E16868 Q27692644-31E2559B-EB73-4BEF-8791-8BE2A6DEAB5A Q28543254-3C4287DB-CCE8-43EE-A8FF-665C07153FF9 Q28584257-FECD1406-D1DB-404C-94A9-AD4765A9721A Q30395586-F44FBE29-3F04-4069-9781-07ED6BDBCC8C Q30568967-229876DE-C1DB-4CD4-A4D2-D80C392B9A0D Q30828492-09919850-7AEA-446E-9DAF-FB7CCA50CAD3 Q31031847-4B19A18E-FF8C-4C6A-9B70-2540ABBFFF82 Q33566334-7FF10F2B-88DC-45C9-9324-2A35491971C2 Q33585435-F70394D5-BEB4-4DED-BE22-264D3D5B7151 Q33638781-ABA8094A-CF44-4C55-B927-40C848E487F8 Q33654169-C0C88CBB-6339-4B03-8387-B4C2B531F802 Q33733145-68C68E61-4D20-4008-886B-C2E0960971F5 Q33862360-2B76EC9C-5118-424E-8B98-FC6EB42E35F9 Q34281303-969DB95A-7842-4D00-887E-F9E60D83FF80 Q34282729-DAA328D3-EBFC-4BA4-A272-B42014699F89 Q34292324-AA011D18-E22E-478E-804A-46C59FE843D7 Q34535319-66F87536-925C-4D0A-BF0B-464535A2CA86 Q34655419-1CA461EB-2518-4E0C-B5EE-7CB6F447CCCA Q35047017-E299DBE1-4AC9-4FD7-9C83-C4DF62D8B798 Q35057757-C4354923-AEBB-4460-93AE-AF726256958D Q35137885-D99DC4A7-3A03-4C55-B40D-B878D98E8FCF Q35187253-30DE1677-9FD4-4FEE-A826-63EEA779275A Q35434851-5C791DEC-3C5C-42A5-AA34-24520855FCBF Q35941395-02E99651-12A4-4432-84FC-1D62CAA27C6B Q36022288-433C5211-D7A6-4EFE-83D8-2CBCF4B842F5 Q36022319-1728AB5E-F641-4488-A747-0120D22AC4D7 Q36056147-88A93245-11CA-42E4-99D9-A5C6A347A3E4 Q36071999-DE43A91C-56E6-4488-9AC4-10C7DBF63055 Q36099382-84F15AF8-86B4-4D2F-965B-37EA116E6582 Q36170150-FABD3476-3168-45E3-BF9B-6D86AC022169 Q36183200-66592932-CB20-4916-8E83-2CD05A4FC4FE

P2860

Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.

http://www.wikidata.org/entity/Q48629603

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.

@en

Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.

@nl

type

label

Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.

@en

Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.

@nl

prefLabel

Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.

@en

Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.

@nl

P1433

Q48629603-9E95FE65-01ED-4EB2-B10E-1B208C8A3E30

P1476

Q48629603-49C488E2-56CD-4ADA-97F8-3CDE808C9E50

P2093

Q48629603-06F21BAF-66D2-4D3C-BA24-1F38820478A9

Q48629603-7C6C9FF8-6AF7-4676-9C1D-D36D5DD217B3

Q48629603-C942D531-8669-4B6B-936C-4985D98A23A4

P2860

Q48629603-013D11B3-19F5-4640-B716-9B803C5499AA

Q48629603-030520C5-6FCF-434B-BBF1-BB1DC9C2C814

Q48629603-1322D44D-17AE-4802-B358-330BFE7CA792

Q48629603-25214480-3A3C-4CB6-BB37-CC507634F624

Q48629603-2AE59F82-4D8F-40A5-8A6D-9B02027CF8D5

Q48629603-30928040-CCA5-4BD6-B1E4-32A03A74DEF2

Q48629603-33FE1A9B-0E35-49E9-B57E-7599C36993EC

Q48629603-496ABF8E-AEAF-46B3-84B6-132954B16D1A

Q48629603-5004932C-14F2-4199-A50E-01DDE88704C1

Q48629603-58DE57AC-F774-4FC0-A648-A65541844FF0

P2888

Q48629603-B3F86CD1-5F9C-425A-B3EB-996264AE951D

P304

Q48629603-FC9BBDED-99D9-413B-827B-46C2D589BD6C

P31

Q48629603-DE6C203F-C052-46F6-B1BE-451F6279E63B

P356

Q48629603-B787E508-4BA5-40BC-AB9B-D14A1B8C5A5D

P407

Q48629603-C4BB5759-B788-42AF-9B41-BE2FDFD0435A

P433

Q48629603-888E882F-D1B4-4790-8A4A-F6249E6BE815

P478

Q48629603-001F8993-1EE1-4790-8A99-E5F299CF6D6C

P577

Q48629603-B96DA266-0BFC-4AB7-B7CA-C6E37092EB27

P5875

Q48629603-F8251198-5F92-473B-8200-5D806FADB8CB

P6179

Q48629603-995DCFED-1D97-4238-910F-137E8E8CF7D1

P698

Q48629603-00A6E59D-A6FA-4D22-90D4-ECD667273823

P921

Q48629603-78FADE40-6076-420C-B4BC-BD0E8C048D51

P356

P1433

P1476

Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.

@en

P2093

Douglas J Cook

http://www.w3.org/2001/XMLSchema#string

Lucy Teves

http://www.w3.org/2001/XMLSchema#string

Michael Tymianski

http://www.w3.org/2001/XMLSchema#string

P2860

Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein

Evolutionary and Biomedical Insights from the Rhesus Macaque Genome

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Update of the stroke therapy academic industry roundtable preclinical recommendations

1,026 experimental treatments in acute stroke

Dose translation from animal to human studies revisited

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

P2888

P304

213-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE10841

http://www.w3.org/2001/XMLSchema#string

P407

P433

7388

http://www.w3.org/2001/XMLSchema#string

P478

483

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221886614

http://www.w3.org/2001/XMLSchema#string

P6179

1016115659

http://www.w3.org/2001/XMLSchema#string

P698

22388811

http://www.w3.org/2001/XMLSchema#string

P921